Effects of tempol and redox-cycling nitroxides in models of oxidative stress
- PMID: 20153367
- PMCID: PMC2854323
- DOI: 10.1016/j.pharmthera.2010.01.003
Effects of tempol and redox-cycling nitroxides in models of oxidative stress
Abstract
Tempol is a redox-cycling nitroxide that promotes the metabolism of many reactive oxygen species (ROS) and improves nitric oxide bioavailability. It has been studied extensively in animal models of oxidative stress. Tempol has been shown to preserve mitochondria against oxidative damage and improve tissue oxygenation. Tempol improved insulin responsiveness in models of diabetes mellitus and improved the dyslipidemia, reduced the weight gain and prevented diastolic dysfunction and heart failure in fat-fed models of the metabolic syndrome. Tempol protected many organs, including the heart and brain, from ischemia/reperfusion damage. Tempol prevented podocyte damage, glomerulosclerosis, proteinuria and progressive loss of renal function in models of salt and mineralocorticosteroid excess. It reduced brain or spinal cord damage after ischemia or trauma and exerted a spinal analgesic action. Tempol improved survival in several models of shock. It protected normal cells from radiation while maintaining radiation sensitivity of tumor cells. Its paradoxical pro-oxidant action in tumor cells accounted for a reduction in spontaneous tumor formation. Tempol was effective in some models of neurodegeneration. Thus, tempol has been effective in preventing several of the adverse consequences of oxidative stress and inflammation that underlie radiation damage and many of the diseases associated with aging. Indeed, tempol given from birth prolonged the life span of normal mice. However, presently tempol has been used only in human subjects as a topical agent to prevent radiation-induced alopecia.
Copyright 2010 Elsevier Inc. All rights reserved.
Conflict of interest statement
Figures






Similar articles
-
Tempol, a superoxide dismutase mimetic agent, ameliorates cisplatin-induced nephrotoxicity through alleviation of mitochondrial dysfunction in mice.PLoS One. 2014 Oct 1;9(10):e108889. doi: 10.1371/journal.pone.0108889. eCollection 2014. PLoS One. 2014. PMID: 25271439 Free PMC article.
-
Tempol moderately extends survival in a hSOD1(G93A) ALS rat model by inhibiting neuronal cell loss, oxidative damage and levels of non-native hSOD1(G93A) forms.PLoS One. 2013;8(2):e55868. doi: 10.1371/journal.pone.0055868. Epub 2013 Feb 6. PLoS One. 2013. PMID: 23405225 Free PMC article.
-
Impact of polynitroxylated albumin (PNA) and tempol on ischemia/reperfusion injury: intravital microscopic study in the dorsal skinfold chamber of the Syrian golden hamster.Shock. 2000 Aug;14(2):163-8. doi: 10.1097/00024382-200014020-00015. Shock. 2000. PMID: 10947161
-
The Cellular and Organismal Effects of Nitroxides and Nitroxide-Containing Nanoparticles.Int J Mol Sci. 2024 Jan 24;25(3):1446. doi: 10.3390/ijms25031446. Int J Mol Sci. 2024. PMID: 38338725 Free PMC article. Review.
-
[Nitroxides as antioxidants - possibilities of their application in chemoprevention and radioprotection].Postepy Hig Med Dosw (Online). 2011 Feb 2;65:46-54. doi: 10.5604/17322693.932256. Postepy Hig Med Dosw (Online). 2011. PMID: 21357994 Review. Polish.
Cited by
-
Mitochondria-Targeted Nitronyl Nitroxide Radical Nanoparticles for Protection against Radiation-Induced Damage with Antioxidant Effects.Cancers (Basel). 2024 Jan 13;16(2):351. doi: 10.3390/cancers16020351. Cancers (Basel). 2024. PMID: 38254840 Free PMC article.
-
Diabetes increases mortality after myocardial infarction by oxidizing CaMKII.J Clin Invest. 2013 Mar;123(3):1262-74. doi: 10.1172/JCI65268. Epub 2013 Feb 15. J Clin Invest. 2013. PMID: 23426181 Free PMC article.
-
Nitric oxide generation by the organic nitrate NDBP attenuates oxidative stress and angiotensin II-mediated hypertension.Br J Pharmacol. 2016 Jul;173(14):2290-302. doi: 10.1111/bph.13511. Epub 2016 Jun 12. Br J Pharmacol. 2016. PMID: 27160064 Free PMC article.
-
Prevention of vancomycin induced nephrotoxicity: a review of preclinical data.Eur J Clin Pharmacol. 2013 Apr;69(4):747-54. doi: 10.1007/s00228-012-1406-3. Epub 2012 Sep 21. Eur J Clin Pharmacol. 2013. PMID: 22996076 Review.
-
Role of the intrarenal renin-angiotensin system in the progression of renal disease.Pediatr Nephrol. 2017 Sep;32(9):1471-1479. doi: 10.1007/s00467-016-3449-7. Epub 2016 Jul 5. Pediatr Nephrol. 2017. PMID: 27380400 Review.
References
-
- Adeagbo AS, Joshua IG, Falkner C, Matheson PJ. Tempol, an antioxidant, restores endothelium-derived hyperpolarizing factor-mediated vasodilation during hypertension. Eur J Pharmacol. 2003;481:91–100. - PubMed
-
- Adler A, Messina E, Sherman B, Wang Z, Huang H, Linke A, et al. NAD(P)H oxidase-generated superoxide anion accounts for reduced control of myocardial O2 consumption by NO in old Fischer 344 rats. Am J Physiol. 2003;285:H1015–1022. - PubMed
-
- Akiyama N, Umeda IO, Sogo S, Nishigori H, Tsujimoto M, Natori S. 5-S-GAD, a novel radical scavenging compound, prevents lens opacity development. Free Radic Biol Med. 2009;46:511–519. - PubMed
-
- Alpert E, Altman H, Totary H, Gruzman A, Barnea D, Barash V, et al. 4-Hydroxy tempol-induced impairment of mitochondrial function and augmentation of glucose transport in vascular endothelial and smooth muscle cells. Biochem Pharmacol. 2004;67:1985–1995. - PubMed
-
- Ando K, Fujita T. Metabolic syndrome and oxidative stress. Free Radic Biol Med. 2009;47:213–218. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical